DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and exploitation of bacterial biodiversity to address the urgent, global challenge of antibiotic resistance, informs its shareholders that the Extraordinary Annual General Meeting (AGM) held on July 5, 2022 on a third convening has followed the recommendations of the Board of Directors, and adopted all the resolutions that the Board was favorable to, i.e. 10 out of the 11 resolutions.

The shareholders taking part in the vote owned collectively 2,112,107 shares with voting rights out of the 34,348,696 shares making up the share capital and carrying voting rights, i.e. 6.15% of the share capital.

Considering the appointment of Mr. Vincent AUSSEL in capacity of ad hoc representative (mandataire ad hoc), by order of the President of the Commercial Court of Montpellier dated June 20, 2022, with the mission to represent and act on behalf of the defaulting shareholders, the rights attached to the 32,236,589 shares of such shareholders were exercised by the ad hoc representative so that the quorum was reached with a representation of 100% of the 34,348,696 shares with voting rights. Consequently, the extraordinary resolutions have been debated as listed in the meeting notice published in the French official legal bulletin Bulletin des Annonces Légales Obligatoires (BALO) No 44, dated April 13, 2022.

The voting rights attached to the shares of the defaulting shareholders represented by the ad hoc representative were exercised at a rate of two thirds votes in favor and one third against, pursuant to the terms of the mission entrusted to the ad hoc representative by order of the President of the Commercial Court of Montpellier dated June 20, 2022.

All the documents regarding this AGM, including the results of the votes, are available on the Company's website: http://www.deinove.com/en/investors/documentation-center/shareholders-meetings/extraordinary-shareholders-meeting-july-5-2022

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Deinove SA published this content on 07 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 July 2022 15:53:04 UTC.